- Pharma firm Hepalink soars on trading debut
Shares of drugmaker Shenzhen Hepalink Pharmaceutical Co Ltd soared on the company's trading debut on Thursday against the backdrop of the sharp plunge of the overall market as analysts said it may boost investor interest in the pharmaceutical sector.
The price of Hepalink, the world's largest maker of the blood-thinner heparin, surged 18.36 percent to close at 175.17 yuan ($25.66). It climbed to the intraday high of 188 yuan from its initial public offering (IPO) price of 148 yuan, the highe ... デビュー取引の木曜日に対する背景セクター市場急落の全体の医薬品に興味を可能性があります高める投資家のそれはアナリストらによる会社株式の上に急騰有限公司は、医薬品製薬会社深センHepalink
- Hepalink's decline costs China's richest couple over 5 bln yuan
Shares of Shenzhen Hepalink Pharmaceutical Co. Ltd., which experienced the highest IPO price in China's A-share market last week, dropped by 10 percent in the morning trading, reaching the decline limit.
The drop evaporates the fortune of Li Li and Li Tan, Hepalink's co-founders, by over 5 billion yuan (around 730 million U.S. dollars).
Shares in Chinese heparin producer Shenzhen Hepalink closed up 18% after their debut on the country's emerging markets board, leaving its founders in the r ... 1週間前の株式の深センHepalink製薬株式会社市場のシェアは中国経験の最高のIPO価格を決定し、制限を10ドロップで朝の％で取。衰退、達する
- In Ads, Plea for Asians to Get Tests for Hepatitis
A provocative advertising campaign by San Francisco Hep B Free aims to eradicate the disease with citywide vaccinations against hepatitis B.
サンフランシスコヘパリンBの無料で挑発的な広告キャンペーンは、B型肝炎に対する市全体の予防接種で病気を根絶することを目的
|
